zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
irinotecan eugia 20 mg/ml koncentrat do sporządzania roztworu do infuzji
eugia pharma (malta) ltd. - irinotecani hydrochloridum trihydricum - koncentrat do sporządzania roztworu do infuzji - 20 mg/ml
dormicum 15 mg tabletki powlekane
cheplapharm arzneimittel gmbh - midazolami maleas - tabletki powlekane - 15 mg
dormicum 7,5 mg tabletki powlekane
cheplapharm arzneimittel gmbh - midazolami maleas - tabletki powlekane - 7,5 mg
orungal 100 mg kapsułki
janssen-cilag international n.v. - itraconazolum - kapsułki - 100 mg
itromyx 100 mg kapsułki twarde
adamed pharma s.a. - itraconazolum - kapsułki twarde - 100 mg
irinotecan-ebewe 20 mg/ml koncentrat do sporządzania roztworu do infuzji
ebewe pharma ges.m.b.h nfg. kg - irinotecani hydrochloridum - koncentrat do sporządzania roztworu do infuzji - 20 mg/ml
irinotecan kabi 20 mg/ml koncentrat do sporządzania roztworu do infuzji
fresenius kabi polska sp. z o.o. - irinotecani hydrochloridum - koncentrat do sporządzania roztworu do infuzji - 20 mg/ml
irinotecan accord 20 mg/ml koncentrat do sporządzania roztworu do infuzji
accord healthcare polska sp. z o.o. - irinotecani hydrochloridum trihydricum - koncentrat do sporządzania roztworu do infuzji - 20 mg/ml
irinotecan sun 1,5 mg/ml roztwór do infuzji
sun pharmaceutical industries europe b.v. - irinotecani hydrochloridum trihydricum - roztwór do infuzji - 1,5 mg/ml